Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multicentre Study to Evaluate Maternal and Perinatal Outcomes in Myeloproliferative Neoplasms: MAPP-MPN Trial

NCT07832513 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT07832513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07832513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multicentre Study to Evaluate Maternal and Perinatal Outcomes in Myeloproliferative Neoplasms: MAPP-MPN Trial
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Not yet recruiting
Start date
October 5, 2026
Completion date
October 5, 2028
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

myeloproliferative neoplasm (mpn), pregnancy